http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2020075670-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-3809 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-00 |
| filingDate | 2019-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2020075670-A1 |
| titleOfInvention | Method for separating solid-phase carrier containing IgG-binding peptide and IgG |
| abstract | The present invention provides a solid phase carrier on which an IgG-binding peptide having resistance to repeated washing with an alkaline solution after IgG purification and having a high IgG-binding affinity, which can be used for IgG purification, is immobilized. For the purpose of providing, specifically, in a solid phase carrier on which an IgG-binding peptide is immobilized, two cysteine residues outside the peptide are contained in the following formula: [Chemical formula 1] [in the formula]. , The upper cysteine residue is the N-terminal cysteine residue in the peptide, and the lower cysteine residue is the C-terminal cysteine residue in the peptide]. Regarding solid phase carriers. |
| priorityDate | 2018-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 72.